Order results by:
| Issue | Title | |
| Vol 17, No 1 (2025) | Aggressive multiple sclerosis in the Republic of Bashkortostan | Abstract similar documents |
| K. Z. Bakhtiyarova, U. Sh. Kuzmina, O. V. Lyutov, I. D. Talipova, N. F. Akhmetgaleeva, T. R. Galiullin, M. A. Kutlubaev | ||
| "... Treatment of patients with aggressive multiple sclerosis (MS) characterized by severe progression ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease of the nervous system of a predominantly ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis | Abstract similar documents |
| E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva | ||
| "... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..." | ||
| Vol 10, No 4 (2018) | Environmental factors and a risk for multiple sclerosis in the Altai Territory | Abstract similar documents |
| I. P. Saldan, I. V. Smagina, S. A. Elchaninova | ||
| "... Multiple sclerosis (MS) is a chronic dysimmune neurodegenerative disease of the central nervous ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..." | ||
| Vol 8, No 3 (2016) | Epidemiology of multiple sclerosis in the Bryansk Region | Abstract similar documents |
| Yu. N. Yurchenko, A. N. Yurchenko, I. V. Smagina | ||
| "... Objective: to study the clinical and epidemiological features of multiple sclerosis (MS ..." | ||
| Vol 15 (2023): (Suppl. 1) | Features of multiple sclerosis in childhood in the Republic of Tatarstan | Abstract similar documents |
| A. R. Khaibullina, F. A. Khabirov, T. I. Khaibullin | ||
| "... Multiple sclerosis (MS) in children and adolescents is a genuine concern of pediatric neurology ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... administration, which has moderate efficacy in reducing clinical exacerbations of multiple sclerosis (MS), which ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... The involvement of the visual pathway in multiple sclerosis (MS) pathology determines ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..." | ||
| Vol 16 (2024): (Suppl. 2) | Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis | Abstract similar documents |
| N. S. Baranova, L. A. Ovsyannikova, Ya. S. Ostapenko, N. N. Spirin, A. A. Baranov, M. S. Gris, A. S. Artyukhov, Yu. V. Manyakina | ||
| "... in the pathogenesis of multiple sclerosis (MS) and chronic neuroborreliosis (CNB). Objective: to perform ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is an autoimmune inflammatory neurodegenerative disease of the central ..." | ||
| Vol 17, No 1 (2025) | Contribution of genomic variation to the severity of multiple sclerosis | Abstract similar documents |
| O. G. Kulakova, N. A. Matveeva, I. S. Kiselev, A. N. Boyko, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system of polygenic ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
| I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease, in the pathogenesis of which ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... Currently, special attention is paid to timely treatment for active forms of multiple sclerosis ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Cladribine is a tablet preparation for the treatment of relapsing-remitting multiple sclerosis ..." | ||
| Vol 16, No 6 (2024) | Characteristics of the parent-child relationship in families of children with cerebral palsy and multiple sclerosis (literature review) | Abstract similar documents |
| E. A. Boiko, V. L Malygin, E. I. Glushchenko | ||
| "... Multiple sclerosis (MS) and cerebral palsy (CP) are chronic disabling diseases caused by central ..." | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... dimethyl fumarate in the treatment of multiple sclerosis (MS) in European countries. A pharmacoeconomic ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Analytical epidemiology of multiple sclerosis in the Republic of Kabardino-Balkaria | Abstract similar documents |
| L. B. Tlapshokova, A. R. Zikhova | ||
| "... Multiple sclerosis (MS) is a common autoimmune disease, which etiology includes a complex ..." | ||
| Vol 7, No 1 (2015) | Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use | Abstract similar documents |
| I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova | ||
| "... of multiple sclerosis (MS) – glatiramer acetate (GA, Copaxone®, Teva) in large Russian MS centers ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years ..." | ||
| Vol 17, No 3 (2025) | Multiple sclerosis associated with adalimumab: a case report and systematic review | Abstract similar documents |
| A. A. Tappakhov, T. Ya. Nikolaeva, N. Yu. Gorokhova, L. T. Okoneshnikova, A. N. Ylakhova, E. E. Konnikova | ||
| "... The role of medications as risk factors for the development of multiple sclerosis (MS) remains ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis | Abstract similar documents |
| I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko | ||
| "... to the development/progression of many diseases, including cerebrovascular disease and multiple sclerosis. Von ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Mechanisms of brain protection against autoimmune inflammation | Abstract similar documents |
| A. I. Volkov, M. V. Melnikov, A. N. Boyko | ||
| Vol 12, No 3 (2020) | Vitamin D status in patients with multiple sclerosis: an association with insolation, disease course, and HLA-DRB1 gene polymorphism | Abstract PDF (Eng) similar documents |
| I. V. Smagina, K. V. Lunev, S. A. Elchaninova | ||
| "... on the relationship of multiple sclerosis (MS) to vitamin D supplementation Objective: to assess the relationship ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... in the pathogenesis of multiple sclerosis (MS). Objective: to analyze the association of BAFF gene polymorphisms (rs ..." | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... In multiple sclerosis (MS), the development and introduction of disease-modifying treatments (DMTs ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic | Abstract similar documents |
| E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov | ||
| "... institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss ..." | ||
| Vol 15 (2023): (Suppl. 1) | Contribution of B-lymphocytes to the production of Interleukin-17 in multiple sclerosis | Abstract similar documents |
| N. V. Sursyakova, E. M. Kuklina, T. V. Baidina, I. V. Nekrasova, T. N. Trushnikova | ||
| "... The study of pathogenic systems involved in multiple sclerosis (MS) is essential ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... of patients with multiple sclerosis” on the organization of medical care, diagnosis and treatment of multiple ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
| Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
| "... Objective: to perform a genome-wide polygenic analysis of multiple sclerosis (MS) markers ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... Multiple sclerosis (MS) is an autoimmune-inflammatory and neurodegenerative disease of the central ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Acute inflammatory demyelinating pseudotumor after COVID-19 | Abstract similar documents |
| T. I. Yakushina, D. M. Yakushin, I. O. Shtang | ||
| "... . Such a focus can be a sign of multiple sclerosis onset, be a symptom of acute disseminated encephalomyelitis ..." | ||
| Vol 10, No 2 (2018) | CLIPPERS syndrome | Abstract similar documents |
| T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The combined effect of nuclear and mitochondrial genomes on the risk of developing multiple sclerosis | Abstract PDF (Eng) similar documents |
| M. S. Kozin, I. S. Kiselev, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... Multiple sclerosis (MS) is a severe chronic CNS disease characterized by autoimmune inflammation ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Reduced expression of the tumor necrosis factor gene in blood mononuclear cells in radiologically isolated syndrome – validation of transcriptome analysis results | Abstract similar documents |
| M. S. Kozin, N. M. Baulina, I. S. Kiselev, A. R. Kabaeva, A. N. Boyko, O. O. Favorova, O. G. Kulakova | ||
| "... (MRI) reveals lesions of the white matter of the brain and/or spinal cord characteristic of multiple ..." | ||
| Vol 10, No 3 (2018) | Balo's concentric sclerosis: a clinical case | Abstract PDF (Eng) similar documents |
| I. V. Litvinenko, G. N. Bisaga, V. S. Chirsky, R. F. Gimadutdinov, P. S. Dynin, S. Yu. Golokhvastov, V. Yu. Lobzin | ||
| "... of the central nervous system (CNS), which is currently classified as multiple sclerosis. In recent years ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... multiple sclerosis (RRMS) in remission. Material and methods. 38 patients with RRMS were analyzed (33 women ..." | ||
| Vol 17, No 2 (2025) | Multitarget transcranial magnetic theta-burst stimulation in the correction of cognitive impairment in patients with progressive multiple sclerosis | Abstract PDF (Eng) similar documents |
| A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov | ||
| "... Cognitive impairment (CI) is a common symptom in multiple sclerosis (MS) that significantly ..." | ||
| Vol 16, No 3 (2024) | Optic neuritis in various demyelinating diseases | Abstract PDF (Eng) similar documents |
| A. K. Kalashnikova, D. D. Eliseeva, N. A. Andreeva, N. V. Zhorzholadze, I. A. Ronzina, R. Ts. Bembeeva, N. N. Venediktova, M. R. Kalganova, N. L. Sheremet | ||
| "... glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS ..." | ||
| Vol 12, No 3 (2020) | Anti-MOG associated myelitis | Abstract PDF (Eng) similar documents |
| A. I. Isaykin, O. N. Voskresenskaya, T. I. Kuzminova, E. V. Ermilova, O. V. Stezhko | ||
| "... of anti-MOG associated myelitis at the CI-TXlevel. Differential diagnosis was made between multiple ..." | ||
| Vol 15 (2023): (Suppl. 1) | Clinical course features of atypical demyelinating optic neuritis: case series | Abstract similar documents |
| N. L. Sheremet, D. D. Eliseeva, V. V. Bryukhov, N. A. Andreeva, N. V. Zhorzholadze, Yu. K. Murakhovskaya, A. K. Kalashnikova, M. N. Zakharova | ||
| "... associated with multiple sclerosis (MS), and atypical ON, which are the main clinical manifestation ..." | ||
| 1 - 45 of 45 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
